MY148403A - Aerosol formulation for the inhalation of beta-agonists - Google Patents

Aerosol formulation for the inhalation of beta-agonists

Info

Publication number
MY148403A
MY148403A MYPI20052158A MYPI20052158A MY148403A MY 148403 A MY148403 A MY 148403A MY PI20052158 A MYPI20052158 A MY PI20052158A MY PI20052158 A MYPI20052158 A MY PI20052158A MY 148403 A MY148403 A MY 148403A
Authority
MY
Malaysia
Prior art keywords
inhalation
aerosol formulation
agonists
beta
propellant
Prior art date
Application number
MYPI20052158A
Inventor
Michael Aven
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34979667&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY148403(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MY148403A publication Critical patent/MY148403A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04—Amoebicides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

THE PRESENT INVENTION RELATES TO A PROPELLANT-FREE AEROSOL FORMULATION WHICH [CONTAINS] ONE OR MORE COMPOUNDS OF GENERAL FORMULA 1 WHEREIN THE GROUPS R¹, R², R³ AND X- MAY HAVE THE MEANINGS GIVEN IN THE CLAIMS AND SPECIFICATION, FOR INHALATION.
MYPI20052158A 2004-05-14 2005-05-12 Aerosol formulation for the inhalation of beta-agonists MY148403A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004024452A DE102004024452A1 (en) 2004-05-14 2004-05-14 Aerosol formulation for the inhalation of beta agonists

Publications (1)

Publication Number Publication Date
MY148403A true MY148403A (en) 2013-04-30

Family

ID=34979667

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20052158A MY148403A (en) 2004-05-14 2005-05-12 Aerosol formulation for the inhalation of beta-agonists

Country Status (26)

Country Link
EP (1) EP1809293B1 (en)
JP (1) JP4620730B2 (en)
KR (1) KR101288791B1 (en)
CN (1) CN101056640A (en)
AR (1) AR049096A1 (en)
AU (1) AU2005244414B2 (en)
BR (1) BRPI0511135B8 (en)
CA (1) CA2564379C (en)
DE (1) DE102004024452A1 (en)
DK (1) DK1809293T3 (en)
EA (1) EA012583B1 (en)
EC (1) ECSP067004A (en)
ES (1) ES2575925T3 (en)
HU (1) HUE027780T2 (en)
IL (1) IL179218A (en)
MX (1) MXPA06013216A (en)
MY (1) MY148403A (en)
NO (1) NO20065030L (en)
PE (1) PE20060311A1 (en)
PL (1) PL1809293T3 (en)
SG (1) SG152265A1 (en)
TW (1) TWI356703B (en)
UA (1) UA87312C2 (en)
UY (1) UY28891A1 (en)
WO (1) WO2005110421A2 (en)
ZA (1) ZA200607462B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
JP5270343B2 (en) 2005-08-15 2013-08-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Beta mimetic manufacturing method
WO2007054498A1 (en) * 2005-11-09 2007-05-18 Boehringer Ingelheim International Gmbh Aerosolformulation for inhalation
UY30543A1 (en) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int AEROSOL FORMULATION FOR INHALATION OF BETA- AGONISTS
EP2358350A1 (en) * 2008-11-21 2011-08-24 Boehringer Ingelheim International GmbH Aerosol formulation for the inhalation of beta agonists
WO2010057927A1 (en) * 2008-11-21 2010-05-27 Boehringer Ingelheim International Gmbh Aerosol formulation for the inhalation of beta agonists
WO2014056840A1 (en) 2012-10-09 2014-04-17 Boehringer Ingelheim International Gmbh Beta-2-adrenoceptor agonist for the treatment of cough
CN110062625A (en) 2016-12-12 2019-07-26 勃林格殷格翰国际有限公司 Nintedanib by giving the method for treating interstitial lung disease with Ao Dateluo altogether

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134590A1 (en) * 1981-09-01 1983-03-10 Boehringer Ingelheim KG, 6507 Ingelheim NEW BENZO HETEROCYCLES
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
JPH0637388B2 (en) * 1986-02-17 1994-05-18 千寿製薬株式会社 Aqueous solution
GB9405019D0 (en) * 1994-03-15 1994-04-27 Smithkline Beecham Plc Novel compounds
DE10253282A1 (en) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Treatment of chronic obstructive pulmonary disease, using new or known N-substituted 2-amino-1-(benz-(1,4)-oxazin-3-on-8-yl)-ethanol derivative beta-mimetic agents, suitable for once-daily administration
SI2422786T1 (en) * 2004-04-22 2014-12-31 Boehringer Ingelheim International Gmbh New medicine combinations for treating respiratory diseases
DE102004019539A1 (en) * 2004-04-22 2005-11-10 Boehringer Ingelheim Pharma Gmbh & Co. Kg New drugs for the treatment of respiratory diseases
DE102004024454A1 (en) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel enantiomerically pure beta agonists, process for their preparation and their use as pharmaceuticals
DE102004024451A1 (en) * 2004-05-14 2005-12-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulations for inhalation containing enantiomerically pure beta agonists

Also Published As

Publication number Publication date
UA87312C2 (en) 2009-07-10
EP1809293B1 (en) 2016-03-16
ECSP067004A (en) 2007-02-28
MXPA06013216A (en) 2007-02-08
ZA200607462B (en) 2008-06-25
KR101288791B1 (en) 2013-07-29
HUE027780T2 (en) 2016-11-28
EP1809293A2 (en) 2007-07-25
BRPI0511135B1 (en) 2019-11-12
DK1809293T3 (en) 2016-06-20
AU2005244414A1 (en) 2005-11-24
BRPI0511135A (en) 2007-11-27
AR049096A1 (en) 2006-06-28
TWI356703B (en) 2012-01-21
KR20070022084A (en) 2007-02-23
CA2564379A1 (en) 2005-11-24
EA012583B1 (en) 2009-10-30
ES2575925T3 (en) 2016-07-04
IL179218A0 (en) 2007-03-08
SG152265A1 (en) 2009-05-29
TW200608981A (en) 2006-03-16
CA2564379C (en) 2013-07-30
EA200602017A1 (en) 2007-06-29
AU2005244414B2 (en) 2010-12-09
NO20065030L (en) 2006-11-30
JP4620730B2 (en) 2011-01-26
JP2007537188A (en) 2007-12-20
BRPI0511135B8 (en) 2021-05-25
WO2005110421A3 (en) 2006-03-16
DE102004024452A1 (en) 2005-12-08
WO2005110421A2 (en) 2005-11-24
UY28891A1 (en) 2005-12-30
PL1809293T3 (en) 2016-09-30
CN101056640A (en) 2007-10-17
PE20060311A1 (en) 2006-05-08
IL179218A (en) 2012-10-31

Similar Documents

Publication Publication Date Title
MY148403A (en) Aerosol formulation for the inhalation of beta-agonists
TW200730178A (en) Aerosol formulations for the inhalation of β-agonists
MY148945A (en) Combination of a betamimetic with anticholinergics and/or steroids
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MY148480A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MY150661A (en) Pyridin-3-yl derivatives as immunomodulating agents
IL185611A0 (en) Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same
TW200612950A (en) Quinazolinedione derivatives as PARP inhibitors
TW200801003A (en) Novel compounds
MY149853A (en) Pyridin-4-yl derivatives as immunomodulating agents
WO2006068826A3 (en) 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors
UA83091C2 (en) Pyrido[2,3-d]pyrimidine-2,4-diamines as pde 2 inhibitors
UA85708C2 (en) Benzoxazine-containing pharmaceutical combinations for treating respiratory tract diseases
WO2006116733A3 (en) Protein kinase inhibitors
GB0415365D0 (en) Pyrimidine derivatives
WO2005112633A3 (en) Compounds and compositions for delivering active agents
TW200618801A (en) Pyrimidine derivatives
DE602006020295D1 (en) AZABENZIMIDALZOL DERIVATES, THEIR PREPARATION AND THEIR USE AS ANTICROBIAL AGENTS
HK1118534A1 (en) Thieno-pyrimidine compounds having fungicidal activity
WO2007120333A3 (en) Tetracyclic kinase inhibitors
WO2006056696A3 (en) 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
MX2007000240A (en) Phenyl substituted [1.2]-oxazine-3,5-dione and dihydropyrone derivatives.
MY142579A (en) Aerosol formulation for inhalation comprising an anticholinergic
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
WO2007022102A3 (en) Pentacyclic kinase inhibitors